Objectives: Urological chronic pelvic pain syndrome includes interstitial cystitis/painful bladder syndrome (IC/PBS), a chronic bladder pain condition of unknown etiology. Interstitial cystitis/painful bladder syndrome can co-occur with a number of associated conditions such as irritable bowel syndrome and fibromyalgia. The purpose of this study was to estimate the heritability of approximately 20 associated conditions in first-degree relatives (and if appropriate, second-and third-degree relatives) of patients with IC/PBS to identify shared genetic contributions for the disease combinations.
U rological chronic pelvic pain syndrome is a global term that includes interstitial cystitis (IC)/painful bladder syndrome (IC/PBS) and chronic prostatitis/chronic pelvic pain syndrome. Interstitial cystitis/painful bladder syndrome is a chronic bladder pain condition that includes urgency, frequency, and/or nocturia. The underlying etiology for IC/PBS is poorly understood, and it is often considered a heterogeneous disease. The prevalence of IC/PBS in women in the United States based on self-report ranges between 2.7% and 6.5% on the basis of high specificity and sensitivity, definitions respectively. 1 In men, the prevalence of IC/ PBS ranges between 1.9% and 4.2% on the basis of high specificity and sensitivity definitions. 2 Interstitial cystitis/painful bladder syndrome greatly impacts quality of life, employment, and relationships. 3 Interstitial cystitis/painful bladder syndrome often presents with the co-occurrence of other conditions including irritable bowel syndrome, fibromyalgia, and migraines. [4] [5] [6] [7] [8] [9] A few studies have investigated the risk of associated conditions in relatives of patients with IC/PBS for identification of a potential syndrome. [10] [11] [12] These studies provide evidence that co-occurrence of IC/PBS and other associated conditions takes place not only within patients with IC/ PBS but also across their relatives. However, these studies have typically focused on a limited number of families, required a self-report of symptoms, required subject/family participation, and have studied only a limited number of associated conditions.
In this study, we estimated the relative risk (RR) of approximately 20 associated conditions in patients with IC/PBS and their first-degree relatives (and if appropriate, second-and third-degree relatives) on the basis of uniform physician diagnosis codes (ie, International Classification of Diseases, Ninth Revision [ICD-9] codes). We hypothesized that studying the heritability of IC/PBS and associated conditions will identify shared genetic contributions for the disease combinations and may lead to identification of more homogeneous subgroups of IC/PBS that will be very useful for future genetic studies.
MATERIALS AND METHODS

Utah Population Database
We used the Utah Population Database (UPDB), a unique population-based, computerized genealogical database for the state of Utah. The UPDB was originally composed of genealogical records of Utah, compiled by members of The Church of Jesus Christ of Latter-day Saints, and submitted to the Genealogical Society of Utah. 13, 14 The original genealogy had approximately 1.6 million individual records for 186,000 three-generation families. Utah birth certificate information (mother, father, and child) has since been linked to extend the genealogy to the present day. The UPDB now includes nearly 15 million records; some pedigrees are up to 11 generations. The UPDB is 1 of only 2 such population-based genealogical databases in the world, the other being in Iceland. Electronic patient records for the University of Utah Health Sciences Center (UUHSC) have been linked to the UPDB genealogy information back in 1994 for 1.7 million patients. Rates of medical record linking to the UPDB vary slightly according to sex (eg, women are more difficult to link because of surname changes with marriage), diagnosis, birthplace (eg, individuals born outside Utah are more difficult to link), and year of birth but have averaged 50% for hospital data. Diagnosis data stored in the UUHSC electronic medical record are coded to ICD-9 and current procedural terminology-4th edition codes.
Our study was approved by the University of Utah Institutional Review Board and the Utah Resource for Genetic and Epidemiologic Research. Informed consent was waived to protect the privacy of subjects; names and other identifying information were not available to the authors of the study.
Diagnosis Codes for IC and Associated Conditions of Interest
Interstitial cystitis/painful bladder syndrome probands were identified by the ICD-9 code of 595.1 (chronic IC). We selected associated conditions that may share some of the possible underlying causes of IC/PBS, including neuropathic pain, inflammatory dysfunction, abnormality of the bladder epithelium, and mast cell activation. We chose associated conditions that have been observed by others to co-occur with IC/PBS 8, 15, 16 as well as other conditions of interest. Associated conditions were required to have at least 200 UUHSC patients who met the genealogy requirement to be included in our list. Table 1 lists the associated conditions of interest, the corresponding ICD-9 codes used for this study, and the number of subjects with the condition.
Estimation of RR
The RR is an estimation of the risk of a disease among relatives of a set of probands compared with the general population, and it provides a way of determining the significance of familial clustering. For a heritable disease or heritable composite of diseases, the risk of the disease(s) will be higher among relatives compared with the general population.
For all subjects involved in this study, we required them to have genealogy information available for parents, all 4 grandparents, and 6 of 8 great grandparents (ie, 12 of their 14 immediate ancestors or at least 3 generations of genealogy information). This genealogy requirement helps to ensure that genealogy quantity and quality are matched in patients and controls. There were 354,738 UUHSC patients who met our strict genealogy requirement and were used in this analysis.
We compared the observed number of cases with an associated condition in relatives of a patient with IC/PBS with the expected number with the associated condition in relatives on the basis of population rates. Only the relatives who were also patients at the UUHSC were considered in this analysis. The number of the observed cases with an associated condition was counted, without duplication, in the patients with IC/PBS and in their first-degree relatives. Risk of the associated condition was estimated in the second-and third-degree relatives if the risk in the first-degree relatives was found to be significant. To estimate the expected number of patients, population rates for each associated condition were required. Population rates for each associated condition were based on assigning all individuals in the UPDB who have been linked to electronic health records at the UUHSC into 137 cohort-specific bins on the basis of sex, birthplace (Utah or elsewhere), and 5-year birth cohorts (34 birth-year cohort bins Â 2 sex bins Â 2 birthplace bins = 136 bins + 1 unknown sex bin). Cohort-specific rates for each associated condition were estimated by dividing the number with the associated condition in each cohort by the total number in the cohort. The RR was estimated among the relatives of patients as the ratio of observed to expected number of patients with the associated condition. The RR is assumed to follow a Poisson distribution with the mean value equal to the number of expected patients with the associated condition among the relatives of patients with IC/PBS. We have used this methodology for the study of multiple diseases. 17-22
RESULTS
We identified 248 subjects with a diagnosis of chronic IC: 228 women and 20 men. Table 2 shows the RR estimates for each associated condition in the 248 subjects with chronic IC. As can be seen, all associated conditions except type 1 diabetes and lupus erythematosus were found to be in significant excess in the patients with IC/PBS. Table 3 lists the RR estimates for each associated condition in 761 first-degree relatives, who were also patients at the UUHSC, of the 248 subjects with chronic IC. Four of the associated conditions were found to be in significant excess in the first-degree relatives. The 4 associated conditions were irritable bowel syndrome, myalgia and myositis/unspecified (fibromyalgia), constipation, as well as anxiety and panic disorder. We also investigated the risk of IC/PBS among the first-degree We further explored the heritability of these 4 associated conditions in 1382 second-degree relatives and 3091 third-degree relatives of the IC/PBS cases who were also patients at the UUHSC; the results are shown in Table 4 . Myalgia and myositis/unspecified (fibromyalgia) as well as constipation were found to be in significant excess in the second-degree relatives but not in the thirddegree relatives. Because constipation can occur with irritable bowel syndrome, we looked for overlap of the first-and seconddegree relatives who had both constipation and irritable bowel syndrome. Among the first-degree relatives, we identified 5 relatives who had both irritable bowel syndrome (5/18 relatives diagnosed with irritable bowel syndrome) and constipation (5/36 relatives diagnosed with constipation). Among the second-degree relatives, we identified 9 relatives who had both irritable bowel syndrome (9/19 relatives diagnosed with irritable bowel syndrome) and constipation (9/59 relatives diagnosed with constipation). Among both the first-and second-degree relatives, most of those with constipation or irritable bowel syndrome had been diagnosed with only 1 of the conditions. As a further test for the strength of the familial relationships of IC/PBS with the 2 associated conditions, myalgia and myositis/unspecified (fibromyalgia) as well as constipation, we estimated the risk of IC/PBS among the first-, second-, and third-degree relatives of probands with each condition, respectively. The results are presented in Table 5 . The first-and second-degree relatives of probands with myalgia and myositis/unspecified (fibromyalgia) were significantly at increased risk of IC/PBS as were the first-and second-degree relatives of probands with constipation.
DISCUSSION
We have examined the familial clustering of IC/PBS with approximately 20 associated conditions. We found that 2 associated conditions, myalgia and myositis/unspecified (fibromyalgia) as well as constipation, are in significant excess in the patients with IC/PBS themselves, their first-degree relatives, and their second-degree relatives. Moreover, the familial relationship between IC/PBS and these 2 associated conditions holds even in the converse direction. Excess risk of IC/PBS was observed in the first-and second-degree relatives of probands with myalgia and myositis/unspecified (fibromyalgia) and in probands with constipation.
It is recognized that IC/PBS is likely to have an underlying genetic component on the basis of first-degree relative studies. [23] [24] [25] Excess clustering of a disease in relatives suggests that shared environmental and/or shared genetic factors contribute to the disease process. Excess clustering of a disease in distant relatives, who are less likely to share immediate environments, suggests a genetic contribution. Because we observed an excess risk of IC/PBS and these 2 associated conditions in the second-degree relatives who are less likely to share immediate environments, there may be an underlying genetic contribution to the combination of diseases. Perhaps, genetic abnormalities behind 1 condition may cause other seemingly unrelated disorders. However, 15, 16, 26, 27 is well established within patients themselves. However, to our knowledge, the risk of these associated conditions in first-, second-, and third-degree relatives has not been previously described. Although the etiology of IC/PBS is unknown, these associated conditions may lead us to hypothesize the various mechanisms by which these seemingly unrelated conditions cooccur. For example, IC/PBS and fibromyalgia may share common central neurophysiologic mechanisms such as abnormalities in sensory processing, autonomic function, and the hypothalamicpituitary-adrenal axis 27 such that these physiological similarities could be attributable to the same genetic etiology. The cooccurrence of constipation with IC/PBS has been assumed to occur because of a joint diagnosis of irritable bowel syndrome and IC/PBS or because of use of medications prescribed to treat IC/ PBS (eg, tricyclic antidepressants). Peters et al 28 identified constipation in childhood and adolescence as a condition of interest in the natural history of IC/PBS. Although we have shown an excess familiality of IC/PBS and constipation, there may be some shared underlying genetic factors that contribute pathologically to the function of the hypogastric plexus resulting in generalized pelvic pain originating from the bladder and the descending colon. Further understanding of IC/PBS may be gained by taking a multidisciplinary approach to this complex condition, including genetic, bowel, and nerve/muscle specialists.
There are 2 other studies that examined the risk of associated conditions in relatives of patients with IC/PBS. Weissman et al 11, 12 investigated a potential panic disorder syndrome composed of panic disorder, kidney or bladder problems (possibly IC/PBS), serious headaches, thyroid problems, and/or mitral valve prolapse in 34 families ranging in size from 4 to 34 individuals. We observed an increased risk of chronic headaches, mitral valve prolapse, as well as anxiety and panic disorder in the patients with IC/PBS, but only anxiety and panic disorder were observed to be in significant excess among the first-degree relatives of IC/ PBS cases. Eaton et al, 10 using Danish health registers, examined the risk of autoimmune disorders among individuals with schizophrenia and their parents and found 5 autoimmune disorders that appeared more frequently in patients with schizophrenia and their parents: thyrotoxicosis, intestinal malabsorption, acquired hemolytic anemia, IC/PBS, and Sjögren syndrome. We also observed an excess risk of Sjögren syndrome in subjects with IC/PBS but not in their first-degree relatives; we did not investigate any of the other autoimmune disorders. Although there may be specific families in our Utah data set who met the definition for the panic disorder syndrome described by Weissman et al 11, 12 or the syndrome of schizophrenia and autoimmune disorders as described by Eaton et al, 10 most of our subjects do not fit either syndrome profile.
We are not the first to see that IC/PBS is associated with multiple comorbid conditions. Keller et al 7 compared 32 medical comorbidities for 9269 subjects with IC/PBS on the basis of the ICD-9 diagnosis codes with 46,345 randomly selected comparison subjects. They found that the subjects with IC/PBS had significantly higher prevalence of all comorbid conditions studied, except metastatic cancer. Both our study and the study by Keller et al 7 show that individuals diagnosed with IC/PBS are likely to be diagnosed with other comorbid conditions. Perhaps because of the difficulty in diagnosing IC/PBS, patients with IC/PBS encounter more physicians and are more likely to be diagnosed with clinically asymptomatic comorbidities. It also possible that, because of more physician visits, patients with IC/PBS are more likely to report comorbid conditions than patients without IC do. As we have shown in this analysis, it is difficult to study the comorbid conditions in patients with IC themselves. A family approach in studying comorbid conditions as was used here is a means to identify diseases that might share genetic underpinnings. 29 There are limitations in our study. Our sample size of patients with IC/PBS is unexpectedly small. This could be caused by several reasons. There are no urologists or urogynecologists at the UUHSC who specialize in treating IC/PBS; patients with IC/PBS symptoms may seek treatment elsewhere, or we may have many patients at the UUHSC with undiagnosed IC/PBS. Despite our small sample size, we have opted to not use broader diagnosis criteria for IC/PBS and, instead, use the single specific ICD-9 code (595.1, chronic IC) to define IC/PBS for a more homogeneous sample. We used ICD-9 codes to identify patients with IC/PBS and all associated conditions analyzed as part of this study. The ICD-9 codes are primarily used as billing codes, and a patient may be assigned an ICD-9 code as part of "ruling out" a diagnosis or in error. Because IC/PBS and some of these associated conditions can be difficult to diagnose, this may be particularly problematic for patients with IC/PBS who encounter physicians often and must have various diseases "ruled out." There may also be additional patients who have IC/PBS or 1 of the associated conditions who have been censored from this analysis. This includes, for example, individuals who have not sought medical attention, those who received medical care at a facility other than UUHSC, or individuals not included in the genealogy data. This type of censoring will primarily result in an underestimation of the true incidence of IC/PBS or any of the associated conditions, and RR estimates may be conservative. For this study, we analyzed only the risk of 1 associated condition at a time among relatives of IC/PBS probands. There may be potential syndromes that include a combination of IC/PBS and associated conditions in patients with IC/PBS and their family members. Although others have observed an excess familiality of IC/PBS among first-degree relatives, 24, 25 we did not observe an excess. We attribute the lack of excess familiality findings for IC/PBS because of our small sample size of patients. Finally, the founding population of Utah originated from Northern and Western Europe; our results apply to other populations of similar descent.
In conclusion, IC/PBS is most likely a multifactorial disease with genetic and environmental components. We have identified 2 associated conditions, myalgia and myositis/unspecified (fibromyalgia) as well as constipation, that co-occur with IC/PBS, that appear more often in extended relatives, and that may share underlying genetic factors. Further study of extended families with a significant excess number of patients with these associated conditions and IC/PBS may further our knowledge about IC/ PBS etiology.
